Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 12 chart positions in 12 markets.
By chart position
- 🇦🇺AU · True Crime#1755K to 30K
- 🇳🇱NL · True Crime#9610K to 30K
- 🇮🇳IN · True Crime#1511K to 10K
- 🇫🇷FR · True Crime#1891K to 10K
- 🇮🇸IS · True Crime#813K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
13K to 59K🎙 Weekly cadence·32 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
26K to 118K🇦🇺25%🇳🇱25%🇮🇳8%+9 more - Active Followers
Loyal subscribers who consistently listen
7.8K to 35K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Introducing "The Snare"
Jun 16, 2026
Unknown duration
Introducing "Blood and Water"
Apr 28, 2026
28m 06s
Bonus: Sentenced
Nov 19, 2022
7m 27s
Bonus: Amanda and The Other Liz
Aug 11, 2022
46m 02s
The Sunny Balwani Verdict
Jul 8, 2022
6m 39s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/16/26 |  Introducing "The Snare" | Today, we're bringing you the first episode of our new true crime series from 20/20 and ABC Audio, "The Snare." In episode one, police in Idaho Falls bring in a young man named Chris Tapp to answer some questions. This will set him and others on a path they never would've predicted. To get new episodes early, follow "The Snare" for free on Apple Podcasts, Spotify, Amazon Music, or wherever you listen to podcasts. | — | ||||||
| 4/28/26 |  Introducing "Blood and Water"✨ | true crimeinvestigation+3 | — | ABC News20/20+1 | — | true crimeBlood and Water+3 | — | 28m 06s | |
| 11/19/22 | Bonus: Sentenced✨ | Elizabeth HolmesTheranos+3 | — | Theranos | — | Elizabeth HolmesTheranos+3 | — | 7m 27s | |
| 8/11/22 | Bonus: Amanda and The Other Liz✨ | Hulu seriesEmmy nominations+3 | Amanda SeyfriedLiz Meriwether | HuluABC News+2 | — | Amanda SeyfriedLiz Meriwether+5 | — | 46m 02s | |
| 7/8/22 | The Sunny Balwani Verdict✨ | TheranosSunny Balwani+3 | Brad Mielke | ABC NewsTheranos | — | Sunny BalwaniTheranos+3 | — | 6m 39s | |
| 3/6/22 | '20/20': The Rise and Con of Elizabeth Holmes✨ | Elizabeth Holmestrue crime+3 | — | HuluABC News+1 | — | Elizabeth HolmesAmanda Seyfried+3 | — | 1h 17m 19s | |
| 1/5/22 | The Verdict✨ | Elizabeth Holmesfraud trial+5 | — | ABC News | Silicon Valley | Elizabeth Holmesverdict+5 | — | 44m 55s | |
| 12/21/21 | Closing Arguments✨ | criminal trialclosing arguments+4 | — | ABC News | — | Elizabeth Holmesclosing arguments+4 | — | 1h 13m 25s | |
| 12/14/21 | The Defense Rests✨ | trialdefense strategy+5 | — | ABC News | — | Elizabeth Holmesdefense+5 | — | 54m 36s | |
| 12/7/21 | Accusations and Evasions✨ | trialtestimony+3 | Elizabeth Holmes | TheranosABC News | — | Elizabeth HolmesSunny Balwani+5 | — | 1h 11m 39s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 11/30/21 | Reframing the Narrative✨ | trialfraud+3 | — | ABC News | — | Elizabeth Holmestrial+5 | — | 49m 54s | |
| 11/23/21 | The Prosecution Rests & Elizabeth Speaks | In a monumental week in the trial of United States v. Elizabeth A. Holmes, the prosecution introduced its final week of witnesses before resting its case. Among them, a patient who received troubling results from a Theranos HIV test and a journalist whose damaging interviews with Elizabeth were played for the first time in court. And in a literal final-hour shocker, the defense called Elizabeth Holmes to the stand. Did the government bring its case home? Did Elizabeth begin to sway the jury? Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 11/16/21 | The Beginning of the End | In this episode, we hear from two Theranos lab directors -- one who never met Elizabeth or stepped foot into the company's lab, another who ultimately voided more than 50,000 Theranos tests after a damning government inspection. And we hear from an irate investor who says Elizabeth Holmes cut off communication with him when he asked for basic information about the company. Plus, 10 weeks into the trial, with only 24 witnesses out of a possible 181 on the government's initial list having taken the stand, we hear a surprising update from prosecutor Jeffrey Schenk: This week might be the prosecution's last before it rests its case. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 11/9/21 | Patterns | Nine weeks into the criminal trial of Elizabeth Holmes, we've heard from dozens of witnesses -- Elizabeth's colleagues, board members, investors, clients, scientists, accountants and corporate executives. It's impossible not to feel the repetition. We learn that a fake Pfizer memo wasn't the only document Theranos falsified, and we're introduced to a man with deep connections to many of the central players in Elizabeth's orbit. Patterns in the prosecution's questioning are beginning to become clear, and experts show us it's all part of a greater plan. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 11/2/21 | The Investors | This week, we hear from high-profile companies and individuals who invested millions of dollars into Theranos, the prosecution reiterating that these investments were made on the basis of what they say was a pattern of misinformation, exaggeration and outright lies coming from Elizabeth Holmes herself. And we hear from a Pfizer scientist who speaks to the supposedly doctored Pfizer document that Theranos showed investors to help lure them in. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 10/26/21 | The Therabros | This week, we got a peek into how things at Theranos could at times be a full-on family affair. Elizabeth recruited her brother Christian to the company. He, in turn, recruited five of his Delta Tau Delta fraternity brothers to join him. The group would come to be known as "The Therabros." We hear from one Therabro who would rise to the rank of Elizabeth's lead of strategic operations. He interacted with VIP investors, board members, military officials and business partners, and revealed to the court what the government says was a disturbing pattern of misinformation. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 10/19/21 | The Clients | Theranos' biggest clients, Walgreens and Safeway, are on the stand this week, testifying to what exactly they say they were told before signing multimillion-dollar deals with the blood testing startup. In email exchanges, text messages and board presentations, the prosecution paints a picture of deception while the defense claims the industry giants should've known better. Plus, we hear from Sunny Balwani's dermatologist of 15 years, who happened to also become Theranos' lab director. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 10/12/21 | Crime and Punishment | This week, two jurors ask to be excused, citing stress around punishment and the responsibilities in deciding the future of Elizabeth Holmes. A young woman, with unusual ties to this case, gives her perspective as a trial observer, and a veteran Silicon Valley investor puts the Theranos saga in larger context. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 10/5/21 | Sounding the Alarm | This week, we hear some shocking insights from a former Theranos lab director who says he tried to stop the train before it ran off the tracks. From failing machines to a lack of proficiency testing, he tells of the pressure he felt to vouch for tests while maintaining his integrity as a lab director. And he describes how he says he tried to delay the Walgreens launch, pleading with a "nervous" Elizabeth, who went forward nonetheless. But does an aggressive and lengthy cross-examination undermine his claims? Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 9/28/21 | The General and the Patient | This week, a high-profile witness from Elizabeth's superstar board of directors surprises the courtroom by taking the stand: 4-star general and former U.S. Secretary of Defense James Mattis. He speaks of being dazzled by the potential of Theranos' devices on the battlefield and the disillusionment he felt when the full story came to light. Plus, we meet a patient whose Theranos test results led to a terrifying ordeal. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 9/21/21 | Mystery Men | This week, we hear from Erika Cheung, one of the whistleblowers who originally set Elizabeth's downfall in motion and who says she was subjected to disturbing intimidation tactics as a result. Legal experts analyze the success of each side's opening arguments. And a mysterious man named "Hanson" causes quite the stir. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 9/14/21 | Setting the Stage | Elizabeth, holding hands with her partner, Billy and her mother, Noel, breezes into the courthouse to hear opening statements in her financial fraud trial. The government and the defense set the stage, giving us a roadmap of how their sides of the case will unfold. The prosecution says this is a case about fraud, lying and cheating, while the defense paints a picture of an ambitious young woman trying to change the world. She made mistakes, they say, but didn't break the law. And we hear from the case's first witness: Theranos' top ranking financial employee who has a lot to say about how Elizabeth may have misled investors. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 9/7/21 | The Jury | This week, after 11th-hour bombshell allegations of abuse were revealed, we meet the seven men and five women who will ultimately be deciding Elizabeth Holmes' fate. We take a peek inside the courtroom, and speak with some of the potential jurors who were dismissed. We'll hear firsthand what Elizabeth's demeanor is like in the courtroom, what the prosecution and defense appeared to be looking for in a jury, and details about who was actually chosen. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 8/31/21 | Bombshell | Today, after four postponements, a global pandemic and a baby, Elizabeth's long-awaited trial finally begins with jury selection. With millions of pages of discovery, a potential witness list of more than 200, and nearly 4,000 exhibits, Elizabeth's team of heavyweights has their work cut out. And at the 11th hour, the biggest bombshell yet -- Elizabeth's team has alleged that she was subjected to a decade of physical, sexual and psychological abuse. How will this play for a jury? Will Elizabeth take the stand, and what are the chances of a conviction? Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
| 8/31/21 | Where Have You Been, Elizabeth Holmes? | It's been over three years since Elizabeth Holmes was charged with multiple counts of fraud. Once the youngest female self-made billionaire, she was poised to change health care forever. Now she faces decades in prison if convicted. What has Elizabeth been up to while the government has been building its case against her? The answer includes a trip to Burning Man, a new relationship and a baby born just over a month before her trial. Learn more about your ad choices. Visit megaphone.fm/adchoices | — | ||||||
Showing 25 of 32
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart Positions
12 placements across 12 markets.
Chart Positions
12 placements across 12 markets.